Mississippi
Prescription drug spending and prescribing in Mississippi, from Medicare Part D and Medicaid, with the life-science companies raising money there and state attorney general health-care antitrust cases. Compare every state.
In 2024, Medicare Part D plans paid $2.7B for prescriptions written in Mississippi, the 31st most of 52 states and territories, and 4.1% of its claims were opioids against 3.5% nationally.
- Medicare Part D, 2024: $2.7B
- Medicaid drugs, 2025: $595M
- Opioid share of claims: 4.1%
- Life-science raises, 2 years: $6M
How It Prescribes
Medicare Part D, 2024, by the prescriber's state| Share of Part D claims | Mississippi | United States | Difference |
|---|---|---|---|
| Opioids | 4.1% | 3.5% | +15% |
| Antibiotics | 4.7% | 4.4% | +7% |
| Antipsychotics | 1.7% | 1.7% | 0% |
Most Distinctive Drugs
Prescribed most out of line with the rest of the country: the drug's share of Mississippi's claims against its share nationally| Drug | Against national rate | Claims |
|---|---|---|
| Cyproheptadine Hcl | 5.6× | 14,176 |
| Propafenone Hcl | 3.1× | 9,296 |
| Dapaglifloz Propaned/Metformin | 2.9× | 7,422 |
| Megestrol Acetate | 2.8× | 15,574 |
| 0.9 % Sodium Chloride | 2.6× | 9,897 |
| Promethazine Hcl | 2.5× | 36,828 |
| Olmesartan/Hydrochlorothiazide | 2.3× | 25,248 |
| Haloperidol Decanoate | 2.3× | 8,108 |
| Insulin Aspart Prot/Insuln Asp | 2.1× | 7,704 |
| Linaclotide | 2.1× | 58,658 |
Biggest Medicaid Drugs
What Mississippi's Medicaid program paid pharmacies, before rebates; see every drugLife-Science Fundraising
4 Form D raises by companies based in Mississippi in the last two years; the 10 largest. See all raises- Mississippi True$5M · Health insurance · May 22, 2025
- Baptist-Desoto Surgery Center, L.P.$178K · Hospitals and physicians · Dec 3, 2024
- Tiny Miracles Prescribed Pediatric Day Center llc$50K · Other health care · May 8, 2026
- FAQ INVESTMENTS, LLC$50K · Other health care · Sep 10, 2025
State Attorney General Health-Care Cases
Antitrust cases Mississippi joined, newest first; see every case- Connecticut, et al. v. Sandoz, et al., Case No. 20-cv-3539 (E.D. Pa. June 10, 2020), MDL 2724 (E.D. Pa.)2020 · Pending
- Connecticut et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 2:19-cv-02407, (E.D. Pa. filed in MDL 05/30/2019)2019 · Pending
- Alabama et al. v. Endo International, No. 3:19-cv-04157 (N.D. Cal. July 19, 2019)2019 · Settled
- California et al. v. Teikoku Seikayu Co.(Lidoderm), No. 3:18-cv-00675 (N.D. Cal. 01/31/18)2018 · Settled
- State of Wisconsin et al. v. Indivior, No. 16-5073 (E.D. Pa. Sept. 22,2016)2016 · Pending
- New York et al. v. Cephalon, No. 2:16-cv-04234 (E.D. Pa. Aug. 4, 2016)2016 · Settled
- Maryland v. SmithKline Beecham Corp., No. 2:06-cv-01298-JP (E.D.Pa Mar. 27, 2006)2006 · Settled
- State of Colorado et al v. Warner Chilcott, 1:05-cv-02182 (D.D.C.2005)2005 · Settled
- Maryland et al. v. Perrigo Company, No. 1:04CV01398 (D.D.C. Aug. 17, 2004)2004 · Settled
- Texas et al. v. Organon (Remeron), No. 04-5126 (D.N.J. 2004)2004 · Settled
Other States
Alabama · Alaska · Arizona · Arkansas · California · Colorado · Connecticut · Delaware · District of Columbia · Florida · Georgia · Hawaii · Idaho · Illinois · Indiana · Iowa · Kansas · Kentucky · Louisiana · Maine · Maryland · Massachusetts · Michigan · Minnesota · Missouri · Montana · Nebraska · Nevada · New Hampshire · New Jersey · New Mexico · New York · North Carolina · North Dakota · Ohio · Oklahoma · Oregon · Pennsylvania · Puerto Rico · Rhode Island · South Carolina · South Dakota · Tennessee · Texas · Utah · Vermont · Virginia · Washington · West Virginia · Wisconsin · Wyoming
Part D is by the prescriber's state, Medicaid by the paying state program, and Form D by the issuer's stated address. Amounts are before manufacturer rebates. Refreshed weekly. CMS Medicare Part D Prescribers by Geography; CMS State Drug Utilization Data; SEC Form D; NAAG